2013•Annals of HematologyRequires access

Bendamustine compared to fludarabine as second-line treatment in chronic lymphocytic leukemia

N. Niederle, Dirk Megdenberg, Leopold Balleisen, Wolfgang F.W. Heit, Wolfgang Ulrich Knauf, Johann Weiß, Werner Freier, Axel Hinke, Stefan Ibach, Hartmut Eimermacher

Open publisher page 39 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 39 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Bendamustine, Fludarabine, Chronic lymphocytic leukemia, Medicine, Chlorambucil, Internal medicine, Hazard ratio, Regimen

Back to paper search Browse research topics Original source

Bendamustine compared to fludarabine as second-line treatment in chronic lymphocytic leukemia — Research Paper | ScholarLens